tirzepatide and kidney function (Zepbound) showed improved in obese patients with both chronic kidney disease #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https How should Mounjaro (tirzepatide) be

Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford vascular study

The STEP trials evaluated higher-dose semaglutide (2.4 mg weekly) for weight management

Its different for everyone depending on the cause

It protects the body from free radicals, supporting the body's cellular defences and immune system

1 Theres no head-to-head comparison with Mounjaro or Wegovy, so the differences between the trials should be read with caution

New Employer Plan Ushers in a New Era of Access In early March 2026, Eli Lilly rolled out its groundbreaking direct-to-employer Employer Connect program